|
SMi are proud to present the 8th annual Point of Care Diagnostics: Market Adoption and Technology Trends conference scheduled for the 24th and 25th of October 2011.
The need for point of care diagnostics has rapidly increased in an era of mandatory efficiency. Bypassing pathology laboratories and the integration of software interfaces could redirect resources and support comparatively rapid response and action for the patient. Successful adoption of POCT predicts the amelioration of turnaround time, morbidity and mortality in healthcare. The supply and demand for POCT has never been greater and now possesses the momentum and trajectory to circumvent analytical, regulatory, political and commercial constraints.
Key opinion leaders deliver this case study driven conference, orators will provide insight into contemporary issues and success stories equipping delegates with valuable information essential for success in the global market place.
The conference will address:
- Technology trends and advances: Presentation and review of the hottest technology of the year
- Commercial and Regulatory issues: The business case for developing POCT and facilitating the translation of research and gaps in technology
- Developing, BRIC and developed world market review: Analysis of world market trends and identification of demand and gaps in supply.
- Oncology, companion diagnostics and personalised medicine: Pharmaceuticals vs. pharmasuitables and prescribing the appropriate treatment to an individual
|
 |
Current Registered Attendess from the following companies include: Abaxis, Bio Rad Labs, bioMérieux SA. Carclo Technical Plastics, Consort Medical plc, Invetech, Irish Medicines Board, NHS National Innovation Centre, Orion Diagnostica Oy, Qiagen A G, Roche Diagnostics, Sekisui Diagnostics, SPD Development Co LTD, Stratophase Ltd, Systelab Technologies, The Sagentia Group A G, Thinxxs, University Of The West Of England Bristol, Vivacta Ltd & Werfen Group
|
Events Home Page
